nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—CHRM2—Signaling Pathways—FGF1—hematologic cancer	0.000159	0.000159	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CSF2—hematologic cancer	0.000159	0.000159	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	0.000159	0.000159	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MAP2K1—hematologic cancer	0.000159	0.000159	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	0.000159	0.000159	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	0.000158	0.000158	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	0.000158	0.000158	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	0.000158	0.000158	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	0.000158	0.000158	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3CD—hematologic cancer	0.000158	0.000158	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	0.000157	0.000157	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	0.000157	0.000157	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	0.000155	0.000155	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—JAK1—hematologic cancer	0.000155	0.000155	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	0.000155	0.000155	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—JAK1—hematologic cancer	0.000155	0.000155	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	0.000155	0.000155	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	0.000155	0.000155	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—KRAS—hematologic cancer	0.000154	0.000154	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	0.000154	0.000154	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—JAK1—hematologic cancer	0.000153	0.000153	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	0.000153	0.000153	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—FGF2—hematologic cancer	0.000151	0.000151	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3R1—hematologic cancer	0.000149	0.000149	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	0.000145	0.000145	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—JAK2—hematologic cancer	0.000145	0.000145	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	0.000145	0.000145	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3CG—hematologic cancer	0.000144	0.000144	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL2—hematologic cancer	0.000144	0.000144	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL2—hematologic cancer	0.000144	0.000144	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TERT—hematologic cancer	0.000143	0.000143	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	0.000143	0.000143	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TERT—hematologic cancer	0.000143	0.000143	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL2—hematologic cancer	0.000142	0.000142	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—PIK3CA—hematologic cancer	0.000142	0.000142	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TERT—hematologic cancer	0.000142	0.000142	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MDM2—hematologic cancer	0.000141	0.000141	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	0.00014	0.00014	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	0.00014	0.00014	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	0.000138	0.000138	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MTOR—hematologic cancer	0.000137	0.000137	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3CB—hematologic cancer	0.000137	0.000137	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TSC2—hematologic cancer	0.000137	0.000137	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TSC2—hematologic cancer	0.000136	0.000136	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	0.000135	0.000135	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CREBBP—hematologic cancer	0.000134	0.000134	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	0.000132	0.000132	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	0.000131	0.000131	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HRAS—hematologic cancer	0.000131	0.000131	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	0.00013	0.00013	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	0.00013	0.00013	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	0.00013	0.00013	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CDKN1B—hematologic cancer	0.000129	0.000129	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	0.000129	0.000129	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ESR1—hematologic cancer	0.000128	0.000128	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—AKT1—hematologic cancer	0.000127	0.000127	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ESR1—hematologic cancer	0.000127	0.000127	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3CD—hematologic cancer	0.000127	0.000127	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CASP3—hematologic cancer	0.000126	0.000126	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FN1—hematologic cancer	0.000126	0.000126	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	0.000126	0.000126	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL2—hematologic cancer	0.000126	0.000126	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FN1—hematologic cancer	0.000126	0.000126	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—IL6—hematologic cancer	0.000126	0.000126	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ALB—hematologic cancer	0.000125	0.000125	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	0.000125	0.000125	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—BAD—hematologic cancer	0.000125	0.000125	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FN1—hematologic cancer	0.000125	0.000125	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	0.000124	0.000124	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—BAD—hematologic cancer	0.000124	0.000124	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	0.000124	0.000124	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—BAD—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CCND1—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—JUN—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	0.000122	0.000122	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CD80—hematologic cancer	0.000121	0.000121	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—KIT—hematologic cancer	0.000121	0.000121	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	0.000121	0.000121	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	0.000121	0.000121	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CD80—hematologic cancer	0.000121	0.000121	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	0.00012	0.00012	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—KIT—hematologic cancer	0.00012	0.00012	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	0.00012	0.00012	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3R1—hematologic cancer	0.00012	0.00012	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CD80—hematologic cancer	0.00012	0.00012	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—KIT—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CDKN1A—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PTEN—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	0.000118	0.000118	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	0.000117	0.000117	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MAPK8—hematologic cancer	0.000116	0.000116	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—AKT1—hematologic cancer	0.000116	0.000116	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	0.000116	0.000116	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	0.000115	0.000115	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CREB1—hematologic cancer	0.000115	0.000115	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CREB1—hematologic cancer	0.000115	0.000115	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	0.000114	0.000114	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—BRAF—hematologic cancer	0.000114	0.000114	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	0.000114	0.000114	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—BRAF—hematologic cancer	0.000113	0.000113	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—EP300—hematologic cancer	0.000113	0.000113	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCL2—hematologic cancer	0.000113	0.000113	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL6R—hematologic cancer	0.000112	0.000112	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCL2—hematologic cancer	0.000112	0.000112	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	0.000112	0.000112	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	0.000112	0.000112	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL6R—hematologic cancer	0.000112	0.000112	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	0.000112	0.000112	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	0.000111	0.000111	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	0.000111	0.000111	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	0.000111	0.000111	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3CB—hematologic cancer	0.00011	0.00011	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SRC—hematologic cancer	0.00011	0.00011	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—VEGFA—hematologic cancer	0.000107	0.000107	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	0.000107	0.000107	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	0.000107	0.000107	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	0.000106	0.000106	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—STAT3—hematologic cancer	0.000106	0.000106	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	0.000106	0.000106	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NRAS—hematologic cancer	0.000106	0.000106	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	0.000106	0.000106	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000105	0.000105	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000105	0.000105	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	0.000105	0.000105	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	0.000104	0.000104	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000104	0.000104	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	0.000104	0.000104	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	0.000103	0.000103	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FGF2—hematologic cancer	0.000102	0.000102	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FGF2—hematologic cancer	0.000101	0.000101	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MAPK3—hematologic cancer	0.000101	0.000101	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	0.0001	0.0001	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	0.0001	0.0001	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	0.0001	0.0001	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	9.9e-05	9.9e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MYC—hematologic cancer	9.86e-05	9.86e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TGFB1—hematologic cancer	9.84e-05	9.84e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	9.75e-05	9.75e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—JAK2—hematologic cancer	9.72e-05	9.72e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	9.63e-05	9.63e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	9.56e-05	9.56e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PTEN—hematologic cancer	9.54e-05	9.54e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	9.53e-05	9.53e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	9.52e-05	9.52e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MDM2—hematologic cancer	9.49e-05	9.49e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	9.43e-05	9.43e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	9.4e-05	9.4e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	9.26e-05	9.26e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	9.26e-05	9.26e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	9.23e-05	9.23e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MTOR—hematologic cancer	9.23e-05	9.23e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	9.14e-05	9.14e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	9.14e-05	9.14e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—KRAS—hematologic cancer	9.11e-05	9.11e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—EP300—hematologic cancer	9.1e-05	9.1e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	8.84e-05	8.84e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	8.81e-05	8.81e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	8.73e-05	8.73e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	8.69e-05	8.69e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	8.66e-05	8.66e-05	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	8.6e-05	8.6e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	8.58e-05	8.58e-05	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	8.57e-05	8.57e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	8.52e-05	8.52e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL2—hematologic cancer	8.5e-05	8.5e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CASP3—hematologic cancer	8.49e-05	8.49e-05	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	8.49e-05	8.49e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL2—hematologic cancer	8.48e-05	8.48e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	8.46e-05	8.46e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL6—hematologic cancer	8.44e-05	8.44e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	8.41e-05	8.41e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL2—hematologic cancer	8.4e-05	8.4e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PIK3CA—hematologic cancer	8.37e-05	8.37e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	8.35e-05	8.35e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	8.29e-05	8.29e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—JUN—hematologic cancer	8.27e-05	8.27e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CCND1—hematologic cancer	8.26e-05	8.26e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—JUN—hematologic cancer	8.25e-05	8.25e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	8.18e-05	8.18e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—JUN—hematologic cancer	8.17e-05	8.17e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TP53—hematologic cancer	8.1e-05	8.1e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	8.02e-05	8.02e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	8e-05	8e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	7.99e-05	7.99e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	7.98e-05	7.98e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	7.92e-05	7.92e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	7.9e-05	7.9e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	7.83e-05	7.83e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	7.81e-05	7.81e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	7.8e-05	7.8e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	7.78e-05	7.78e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HRAS—hematologic cancer	7.75e-05	7.75e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	7.73e-05	7.73e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	7.71e-05	7.71e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EP300—hematologic cancer	7.63e-05	7.63e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EP300—hematologic cancer	7.61e-05	7.61e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EP300—hematologic cancer	7.53e-05	7.53e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SRC—hematologic cancer	7.42e-05	7.42e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL6—hematologic cancer	7.41e-05	7.41e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SRC—hematologic cancer	7.4e-05	7.4e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SRC—hematologic cancer	7.33e-05	7.33e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	7.23e-05	7.23e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	7.2e-05	7.2e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	7.16e-05	7.16e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	7.14e-05	7.14e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	7.13e-05	7.13e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	7.13e-05	7.13e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	7.12e-05	7.12e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	7.06e-05	7.06e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	7.05e-05	7.05e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKT1—hematologic cancer	6.84e-05	6.84e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	6.84e-05	6.84e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	6.82e-05	6.82e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	6.75e-05	6.75e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PIK3CA—hematologic cancer	6.73e-05	6.73e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MYC—hematologic cancer	6.65e-05	6.65e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	6.63e-05	6.63e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MYC—hematologic cancer	6.63e-05	6.63e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	6.61e-05	6.61e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MYC—hematologic cancer	6.56e-05	6.56e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	6.55e-05	6.55e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	6.14e-05	6.14e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	6.13e-05	6.13e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	6.07e-05	6.07e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	5.65e-05	5.65e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	5.63e-05	5.63e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	5.57e-05	5.57e-05	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AKT1—hematologic cancer	5.5e-05	5.5e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TP53—hematologic cancer	5.46e-05	5.46e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TP53—hematologic cancer	5.44e-05	5.44e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TP53—hematologic cancer	5.39e-05	5.39e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	5.22e-05	5.22e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	5.21e-05	5.21e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	5.16e-05	5.16e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL6—hematologic cancer	5e-05	5e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL6—hematologic cancer	4.98e-05	4.98e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL6—hematologic cancer	4.93e-05	4.93e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	4.61e-05	4.61e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	4.6e-05	4.6e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	4.55e-05	4.55e-05	CbGpPWpGaD
